FIT Biotech
About:
FIT Biotech develops GTU technologies and product applications in DNA vaccination and immunogene therapies.
Website: http://www.fitbiotech.com
Top Investors: Sitra, BioFund Management
Description:
FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.
Total Funding Amount:
4.8M EUR
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Tampere, Western Finland, Finland
Founded Date:
1995-01-01
Contact Email:
info(AT)fitbiotech.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2006-06-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai